OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex proteins. Improving these processes involves modifying various variables, including cell line engineering, media composition, and bioreactor conditions. A key goal is to maximize antibody titer while minimizing production expenses